Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of DW5421A/DW5421B Compared to Monotherapy of DW5421A

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
This is a multicenter, randomized, double-blind, active-controlled, parallel, phase III clinical trial to evaluate the efficacy and safety of combination therapy of DW5421A/DW5421B versus monotherapy of DW5421A in patients with primary hypercholesterolemia or mixed dyslipidemia.
Epistemonikos ID: 39a308d3d90ddd86ad9007ccda452a3ace29f8d7
First added on: Mar 04, 2026